1. Home
  2. ATEC vs FOLD Comparison

ATEC vs FOLD Comparison

Compare ATEC & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATEC
  • FOLD
  • Stock Information
  • Founded
  • ATEC 1990
  • FOLD 2002
  • Country
  • ATEC United States
  • FOLD United States
  • Employees
  • ATEC N/A
  • FOLD N/A
  • Industry
  • ATEC Medical/Dental Instruments
  • FOLD Biotechnology: Pharmaceutical Preparations
  • Sector
  • ATEC Health Care
  • FOLD Health Care
  • Exchange
  • ATEC Nasdaq
  • FOLD Nasdaq
  • Market Cap
  • ATEC 2.3B
  • FOLD 2.5B
  • IPO Year
  • ATEC 2006
  • FOLD 2007
  • Fundamental
  • Price
  • ATEC $15.87
  • FOLD $8.43
  • Analyst Decision
  • ATEC Strong Buy
  • FOLD Strong Buy
  • Analyst Count
  • ATEC 8
  • FOLD 8
  • Target Price
  • ATEC $17.13
  • FOLD $27.88
  • AVG Volume (30 Days)
  • ATEC 2.0M
  • FOLD 5.3M
  • Earning Date
  • ATEC 10-30-2025
  • FOLD 11-04-2025
  • Dividend Yield
  • ATEC N/A
  • FOLD N/A
  • EPS Growth
  • ATEC N/A
  • FOLD N/A
  • EPS
  • ATEC N/A
  • FOLD N/A
  • Revenue
  • ATEC $682,236,000.00
  • FOLD $571,160,000.00
  • Revenue This Year
  • ATEC $23.76
  • FOLD $21.12
  • Revenue Next Year
  • ATEC $18.20
  • FOLD $21.23
  • P/E Ratio
  • ATEC N/A
  • FOLD N/A
  • Revenue Growth
  • ATEC 26.27
  • FOLD 25.35
  • 52 Week Low
  • ATEC $5.08
  • FOLD $5.51
  • 52 Week High
  • ATEC $16.70
  • FOLD $12.65
  • Technical
  • Relative Strength Index (RSI)
  • ATEC 65.36
  • FOLD 56.53
  • Support Level
  • ATEC $13.14
  • FOLD $7.87
  • Resistance Level
  • ATEC $14.05
  • FOLD $8.62
  • Average True Range (ATR)
  • ATEC 0.59
  • FOLD 0.30
  • MACD
  • ATEC 0.26
  • FOLD 0.00
  • Stochastic Oscillator
  • ATEC 97.67
  • FOLD 75.17

About ATEC Alphatec Holdings Inc.

Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: